A new therapeutic challenge for old pathogens: Community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis

21Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recently, antimicrobial resistance among nontyphoid Salmonella serotypes has been increasingly recognized. In southern Taiwan, we encountered 3 cases of invasive infections caused by Salmonella enterica serotype Choleraesuis with resistance to ciprofloxacin and ceftriaxone. Resistance to ciprofloxacin was related to nucleotide mutations in gyrA and parC, and resistance to ceftriaxone was related to the presence of CMY-2 β-lactamase.

Cite

CITATION STYLE

APA

Ko, W. C., Yan, J. J., Yu, W. L., Lee, H. C., Lee, N. Y., Wang, L. R., & Chuang, Y. C. (2005). A new therapeutic challenge for old pathogens: Community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis. Clinical Infectious Diseases, 40(2), 315–318. https://doi.org/10.1086/426593

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free